Impact of copay maximizers on total patient liability among patients using specialty medicines
Our results indicated that copay maximizer programs are associated with an increase in patient liability for other health care services, especially for patients who relied heavily on the maximizer drug to meet deductible requirements or OOP maximums. These findings should be factored into decisions and policies on implementing and regulating these programs.
Authors
- Daniel Sheinson
- William B. Wong (ORCID: https://orcid.org/0000-0002-6054-278X)
- Achal Patel
Publication Details
- Journal
- Journal of Managed Care & Specialty Pharmacy
- Published
- 2025-09-26
- DOI
- https://doi.org/10.18553/jmcp.2025.31.10.982
- Primary Topic
- Medical Malpractice and Liability Issues
- Type
- article
- Field-Weighted Citation Impact
- 0.00